RBGLY logo

Reckitt Benckiser Group plc (RBGLY) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Reckitt Benckiser Group plc (RBGLY) opera en el sector Consumer Defensive, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 48/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 15 mar 2026
Puntuación de IA de 48/100

Reckitt Benckiser Group plc (RBGLY) Descripción General del Negocio al Consumidor

CEOKristoffer Loe Licht
Empleados37900
Sede CentralSlough, GB
Año de la oferta pública inicial (OPI)2008

Reckitt Benckiser Group plc (RBGLY) is a global leader in consumer health, hygiene, and nutrition, distinguished by its diverse brand portfolio including Dettol, Lysol, and Durex. The company's focus on innovation and market expansion positions it strongly within the competitive household and personal products sector.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 15 mar 2026

Tesis de Inversión

Reckitt Benckiser Group plc presents a compelling investment case based on its strong brand portfolio, global presence, and focus on consumer health and hygiene. The company's diverse product range provides resilience against economic cycles, while its expansion into emerging markets offers significant growth potential. With a P/E ratio of 12.79 and a profit margin of 25.2%, RBGLY demonstrates financial stability. The dividend yield of 8.58% is attractive for income-seeking investors. Ongoing catalysts include continued innovation in its core product categories and strategic acquisitions to expand its market reach. Potential risks include currency fluctuations and increasing competition from private-label brands. Investors should monitor RBGLY's ability to maintain its brand strength and adapt to changing consumer preferences.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $49.75 billion reflects RBGLY's significant presence in the consumer goods industry.
  • Profit margin of 25.2% indicates strong operational efficiency and pricing power.
  • Gross margin of 60.7% highlights the value of RBGLY's brand portfolio and product mix.
  • Dividend yield of 8.58% provides an attractive income stream for investors.
  • Beta of 0.10 suggests low volatility compared to the overall market.

Competidores y Pares

Fortalezas

  • Strong brand recognition and customer loyalty.
  • Global presence and diversified product portfolio.
  • Focus on innovation and product development.
  • Efficient supply chain and distribution network.

Debilidades

  • Exposure to currency fluctuations.
  • Dependence on a few key brands.
  • Potential for product liability claims.
  • Sensitivity to changes in consumer preferences.

Catalizadores

  • Ongoing: Continued demand for hygiene products due to increased awareness of health and safety.
  • Ongoing: Expansion into emerging markets with growing middle-class populations.
  • Upcoming: Launch of new innovative products in the health and nutrition segments in Q3 2026.
  • Ongoing: Strategic acquisitions to expand product portfolio and market reach.
  • Ongoing: Focus on sustainability initiatives to enhance brand image and attract environmentally conscious consumers.

Riesgos

  • Potential: Currency fluctuations impacting revenue and profitability.
  • Potential: Increasing competition from private-label brands.
  • Ongoing: Changes in regulations and consumer preferences.
  • Potential: Economic downturns and reduced consumer spending.
  • Ongoing: Disruptions in the supply chain due to geopolitical events or natural disasters.

Oportunidades de crecimiento

  • Expansion in Emerging Markets: RBGLY can leverage its established brands to expand its presence in high-growth emerging markets like China and India. These markets offer significant opportunities due to increasing disposable incomes and growing demand for health and hygiene products. The emerging markets contribute over 30% of RBGLY's revenue, with a target to increase this to 40% by 2030.
  • Product Innovation: Investing in research and development to launch innovative products in its core categories can drive organic growth. RBGLY can focus on developing sustainable and eco-friendly products to cater to environmentally conscious consumers. The company allocates approximately 3% of its revenue to R&D, with a focus on developing new formulations and packaging solutions.
  • Strategic Acquisitions: Acquiring complementary brands and businesses can expand RBGLY's product portfolio and geographic reach. The company can target acquisitions in high-growth segments like vitamins, minerals, and supplements (VMS). RBGLY has a track record of successful acquisitions, including the acquisition of Mead Johnson Nutrition in 2017, which strengthened its position in the infant nutrition market.
  • E-commerce Growth: Focusing on expanding its online presence and e-commerce capabilities can drive sales and improve customer engagement. RBGLY can invest in digital marketing and partnerships with e-commerce platforms to reach a wider audience. E-commerce currently accounts for approximately 15% of RBGLY's revenue, with a target to increase this to 25% by 2028.
  • Sustainability Initiatives: Implementing sustainable practices and reducing its environmental footprint can enhance RBGLY's brand image and attract environmentally conscious consumers. The company can focus on reducing its carbon emissions, using sustainable packaging materials, and promoting responsible consumption. RBGLY has committed to reducing its carbon emissions by 50% by 2030 and using 100% recyclable packaging by 2025.

Oportunidades

  • Expansion in emerging markets.
  • Acquisition of complementary brands and businesses.
  • Growth in e-commerce and online sales.
  • Development of sustainable and eco-friendly products.

Amenazas

  • Increasing competition from private-label brands.
  • Changes in regulations and consumer preferences.
  • Economic downturns and reduced consumer spending.
  • Disruptions in the supply chain.

Ventajas competitivas

  • Strong brand portfolio with well-known and trusted brands like Dettol, Lysol, and Durex.
  • Global presence with operations in numerous countries, providing diversification and access to different markets.
  • Focus on innovation and product development, allowing the company to stay ahead of competitors and meet evolving consumer needs.
  • Efficient supply chain and distribution network, ensuring products are available to customers in a timely and cost-effective manner.

Acerca de RBGLY

Reckitt Benckiser Group plc, founded in 1819 and headquartered in Slough, United Kingdom, is a multinational consumer goods company focused on health, hygiene, and nutrition. The company's evolution from a starch manufacturer to a global powerhouse reflects its ability to adapt to changing consumer needs and market dynamics. RBGLY's product portfolio is organized into key segments, including hygiene, health, and nutrition. Its hygiene products, marketed under brands like Dettol and Lysol, focus on disinfection and cleaning. The health segment includes brands like Nurofen, Strepsils, and Mucinex, offering solutions for pain relief, sore throat, and cough and cold. The nutrition segment, anchored by brands like Enfamil and Nutramigen, provides infant and toddler nutrition products. RBGLY operates in numerous countries, with a significant presence in the United Kingdom, the United States, China, and India. The company competes with other major players in the consumer goods industry, emphasizing innovation, brand strength, and operational efficiency to maintain its market position.

Qué hacen

  • Manufactures and sells health, hygiene, and nutrition products.
  • Offers disinfection and hygiene products under the Dettol and Lysol brands.
  • Provides pain relief and cold and flu remedies under the Nurofen and Mucinex brands.
  • Markets infant and toddler nutrition products under the Enfamil and Nutramigen brands.
  • Sells condoms, sex toys, and lubricants under the Durex brand.
  • Offers home cleaning products under the Finish and Harpic brands.
  • Provides vitamins, minerals, and supplements under the Airborne and Move Free brands.

Modelo de Negocio

  • Develops, manufactures, and markets a wide range of consumer health, hygiene, and nutrition products.
  • Distributes products through various channels, including retail stores, pharmacies, and e-commerce platforms.
  • Invests in brand building and marketing to create strong brand recognition and customer loyalty.
  • Focuses on innovation and product development to meet evolving consumer needs.

Contexto de la Industria

Reckitt Benckiser Group plc operates in the competitive household and personal products industry, which is characterized by evolving consumer preferences and increasing demand for health and hygiene products. The global market for household and personal care products is estimated at over $500 billion, with a projected growth rate of 3-5% annually. RBGLY competes with major players like DANOY (Danone), DGEAF (Diageo), GPDNF (Grupo Nutresa), HEINY (Heineken), and HELKF (Haleon). The company's focus on innovation, brand building, and strategic acquisitions positions it to capitalize on market trends and maintain its competitive edge.

Clientes Clave

  • Consumers seeking health and hygiene products for personal and household use.
  • Parents looking for infant and toddler nutrition products.
  • Individuals seeking pain relief and cold and flu remedies.
  • Retailers and pharmacies that sell RBGLY's products to consumers.
Confianza de la IA: 82% Actualizado: 15 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Reckitt Benckiser Group plc (RBGLY): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para RBGLY.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para RBGLY.

MoonshotScore

48/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de RBGLY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Kristoffer Loe Licht

CEO

Kristoffer Loe Licht is the Chief Executive Officer of Reckitt Benckiser Group plc. His career spans various leadership roles in the consumer goods industry. Before joining Reckitt Benckiser, he held senior positions at prominent companies, focusing on strategy, marketing, and operations. Licht's experience includes leading global teams and driving growth in diverse markets. He brings a strong understanding of consumer behavior and market dynamics to his role at RBGLY.

Historial: Since becoming CEO, Kristoffer Loe Licht has focused on streamlining RBGLY's operations, strengthening its brand portfolio, and driving innovation. Key initiatives include expanding the company's presence in emerging markets and investing in digital capabilities. Under his leadership, RBGLY has continued to deliver solid financial performance and maintain its position as a leading player in the consumer goods industry.

Información de ADR de Reckitt Benckiser Group plc No patrocinado

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. RBGLY, as an ADR, allows U.S. investors to invest in Reckitt Benckiser Group plc without the complexities of cross-border transactions. Each RBGLY ADR represents a specific number of RBGL shares, simplifying ownership and trading for U.S. investors.

  • Ticker del mercado local: London Stock Exchange, United Kingdom
  • Nivel de ADR: 1
  • Ratio de ADR: 1:1
  • Ticker del mercado local: RBGL
Riesgo cambiario: Investing in RBGLY exposes U.S. investors to currency risk, as the ADR's value can fluctuate based on changes in the exchange rate between the U.S. dollar and the British pound. A stronger pound relative to the dollar can increase the ADR's value, while a weaker pound can decrease it. Investors may want to evaluate this currency risk when evaluating RBGLY's potential returns.
Implicaciones fiscales: Dividends paid on RBGLY ADRs may be subject to foreign dividend withholding tax in the United Kingdom. The standard withholding tax rate is typically 20%, but this may be reduced or eliminated depending on tax treaties between the U.S. and the U.K. U.S. investors may be able to claim a foreign tax credit on their U.S. tax return for the amount of foreign tax withheld.
Horario de negociación: The London Stock Exchange (LSE) typically operates from 8:00 AM to 4:30 PM GMT, while U.S. markets operate from 9:30 AM to 4:00 PM EST. This means there is a partial overlap in trading hours. U.S. investors may experience limited trading activity and liquidity in RBGLY ADRs outside of U.S. market hours.

Información del mercado OTC de RBGLY

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and transparency compared to listed companies. Information availability and trading volume are often significantly lower.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for RBGLY on the OTC market is likely to be limited, which can result in wider bid-ask spreads and difficulty in executing large trades without significantly impacting the price. Lower trading volumes can also increase the volatility of the stock. Investors should be aware of these liquidity constraints when trading RBGLY on the OTC market.
Factores de riesgo OTC:
  • Limited financial disclosure and transparency.
  • Lower trading volume and liquidity.
  • Wider bid-ask spreads.
  • Potential for price manipulation.
  • Higher risk of fraud or misrepresentation.
Lista de verificación de diligencia debida:
  • Verify the company's registration and legal status.
  • Obtain and review available financial statements.
  • Assess the company's management team and track record.
  • Research the company's products and services.
  • Evaluate the company's competitive position.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor.
Señales de legitimidad:
  • Established brand name and reputation.
  • Global presence and operations.
  • History of financial performance.
  • Presence of institutional investors.
  • Compliance with regulatory requirements in its home market.

Preguntas Comunes Sobre RBGLY

¿Cuáles son los factores clave para evaluar RBGLY?

Reckitt Benckiser Group plc (RBGLY) actualmente tiene una puntuación IA de 48/100, indicando puntuación baja. Fortaleza clave: Strong brand recognition and customer loyalty.. Riesgo principal a monitorear: Potential: Currency fluctuations impacting revenue and profitability.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de RBGLY?

RBGLY actualmente puntúa 48/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de RBGLY?

Los precios de RBGLY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre RBGLY?

La cobertura de analistas para RBGLY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en RBGLY?

Las categorías de riesgo para RBGLY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Currency fluctuations impacting revenue and profitability.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de RBGLY?

La relación P/E para RBGLY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está RBGLY sobrevalorada o infravalorada?

Determinar si Reckitt Benckiser Group plc (RBGLY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de RBGLY?

Reckitt Benckiser Group plc (RBGLY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on available financial data and company reports as of 2026-03-15.
  • AI analysis is pending and may provide further insights.
Fuentes de datos

Popular Stocks